ACELYRIN, INC. Announces Magnitude of Clinical Responses with Izokibep in Psoriatic Arthritis Continues to Improve with Longer Duration of Therapy
LOS ANGELES, April 11, 2023. ACELYRIN, INC., a late-stage clinical biopharma company focused on acceleratin
Resident Doctors Long Work Shifts Could Bring Peril to Patients
FRIDAY, April 14, 2023 -- Early-career doctors were more likely to make mistakes when they had long work weeks or extended shifts, new research reveals.
Their patients were also more like
Machine Learning IDs Factors Predicting Risk for Sleep Disorder Diagnosis
FRIDAY, April 14, 2023 -- Machine learning models can effectively predict risk for a sleep disorder using demographic, laboratory, physical exam, and lifestyle covariates, accordin
Air Pollution May Create U.S. Hot Spots for Parkinsons Risk
FRIDAY, Feb. 24, 2023 -- People living in heavily polluted areas of the United States may be more vulnerable to Parkinson’s disease, a new study suggests.
Specifically, the culprit is a type
Scientists Grow Electrodes in Living Tissue
FRIDAY, Feb. 24, 2023 -- Swedish scientists say they have grown electrodes in living tissue, paving the way for formation of fully integrated electronic circuits in living organisms.
The development, which b
FRIDAY, Feb. 24, 2023 -- Pretransplant screening chest computed tomography (CT) is beneficial for identifying abnormalities before allogenic hematopoietic stem cell transplant (alloHSCT), according to a study published online Feb. 3 in Transplantation and